Literature DB >> 13801314

Griseofulvin for the systemic treatment of dermatomycoses.

H BLANK, J G SMITH, F J ROTH, N ZAIAS.   

Abstract

Keywords:  DERMATOMYCOSIS/therapy; GRISEOFULVIN/therapy

Mesh：

Substances：

Year:  1959        PMID： 13801314     DOI： 10.1001/jama.1959.03010340012003

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN： 0002-9955


× No keyword cloud information.
  12 in total

Review 1.  Adverse drug reactions to systemic antifungals. Prevention and management.

Authors:  J R Perfect; M H Lindsay; R H Drew
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

2.  THE CONTROL OF TINEA CAPITIS AMONG INDIGENT POPULATIONS.

Authors:  L FRIEDMAN; V J DERBES; B L NEWELL; E LEE
Journal:  Am J Public Health Nations Health       Date:  1964-09

3.  Mycological and clinical evaluation of griseofulvin for chronic onychomycosis.

Authors:  R R Davies; J D Everall; E Hamilton
Journal:  Br Med J       Date:  1967-08-19

4.  Anti-inflammatory properties of griseofulvin.

Authors:  L Sorrentino; F Capasso; M Di Rosa
Journal:  Agents Actions       Date:  1977-03

5.  In vitro susceptibility of Trichophyton rubrum isolates to griseofulvin and tioconazole. Induction and isolation of a resistant mutant to both antimycotic drugs. Mutant of Trichophyton rubrum resistant to griseofulvin and tioconazole.

Authors:  A L Fachin; C M Maffei; N M Martinez-Rossi
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

Review 6.  Clinical and economic factors in the treatment of onychomycosis.

Authors:  T R Einarson; A K Gupta; N H Shear; S Arikian
Journal:  Pharmacoeconomics       Date:  1996-04       Impact factor: 4.981

Review 7.  [Present status of griseofulvin therapy of tinea pedis].

Authors:  W Adam
Journal:  Arch Klin Exp Dermatol       Date:  1966

8.  Fungal infections of the nails in Western Australia.

Authors:  R McAleer
Journal:  Mycopathologia       Date:  1981-02-13       Impact factor: 2.574

9.  Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis.

Authors:  A K Gupta
Journal:  Pharmacoeconomics       Date:  1998-02       Impact factor: 4.981

10.  Treatment of superficial fungous infections. Value and limitations of systemic administration of griseofulvin.

Authors:  S AYRES; S AYRES
Journal:  Calif Med       Date:  1961-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.